InvestorsHub Logo
Followers 113
Posts 11894
Boards Moderated 0
Alias Born 07/10/2014

Re: Whalatane post# 229037

Thursday, 11/21/2019 12:06:15 AM

Thursday, November 21, 2019 12:06:15 AM

Post# of 426971
GILD has Renexa

GILD CEO said statnews today that they are in acquisition mode. They have 25B+ cash in hand. Plus they have a NASH combo clinical trial with V on going. Their cardio drug Renexa went on generic thus need a Rx CVD drug like V to replace their cardio space. Plus V can help their HIV and RA patients in their cardio and inflammation issues. A good across the board fit for GILD and hence B/O
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News